🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. logo
Market Cap: High
Employees: Medium

NTLA-2001, NTLA-2002, NTLA-5001

Intellia Therapeutics, Inc. is a genome editing company specializing in developing therapeutics, with a focus on in vivo and ex vivo programs, including treatments for transthyretin amyloidosis, hereditary angioedema, and acute myeloid leukemia. The company also develops engineered cell therapies and offers CRISPR/Cas9 tools.

Tags: CRISPR, autoimmune disorders, ex vivo, genome editing, in vivo, oncology, therapeutics

Symbol: NTLA

Recent Price: $11.41

Industry: Biotechnology

CEO: Dr. John M. Leonard M.D.

Sector: Healthcare

Employees: 526

Address: 40 Erie Street, Cambridge, MA 02139

Phone: 857 285 6200

Last updated: 2024-12-31